The variation in individual responses to exogenous agents has been shown to be exceptionally wide. It is because of this large diversity of responsiveness that risk factors to 755-758 (1997) 
Introduction
People are exposed to agents (chemical, physical, and biological) that may contribute to the prevalence of genetic damage and chronic diseases in the population. Many of the diseases are affected by both host factors and the external environment. For instance, although carcinogenesis in humans is known to be significantly influenced by external factors, the metabolic activation or inactivation of the procarcinogens may modulate the process. This is best exemplified by tobacco smoking; cigarette smoking is the main cause of lung cancer but only a minority of smokers develop pulmonary cancers.
Recent findings suggest that inherited differences in metabolic capacity may in fact play a primary role in susceptibility to environmentally induced diseases (1) (2) (3) (4) (1) (2) (3) (4) , but at increased risk of several central nervous system disorders (5) (6) (7) (8) .
Among phase II enzymes, N-acetyltransferases (NATs) and glutathione Stransferases (GSTs) have attracted most of the recent interest. The GST MI (GSTM1) and TI (GSTTI) genes are polymorphic so that the absence of enzyme activity results from a homozygous deletion of the respective gene, called the null genotype (9, 10) . About 50% of Caucasians have the GSTMI null genotype, which may pose an increased risk of various environmentally induced cancers (11) (12) (13) (14) . The GSTTI null genotype, which putatively has a frequency of 15 to 25% in Caucasians, has been associated with enhanced susceptibility to primary brain tumors (astrocytoma and meningioma) (15) , and to myelodysplastic syndromes, which are clonal proliferative disorders of bone marrow that often progress to acute myeloid leukemia (16) .
The human N-acetylation polymorphism is demonstrable by individual variations in metabolism of several substrates, including sulfamethazine and isoniazid (17) . The differences in the metabolism of these compounds distinguish phenotypically slow and fast acetylators. The slow acetylators, whose frequency worldwide ranges from about 10% to more than 90% (18) , may be at increased risk of arylamineinduced cancers (19) (20) (21) (22) .
Previous studies on acetylation polymorphisms have focused on the NAT2 gene locus, and allelic variants of NA T2 gene correlate with differences in acetylation capacity (23) (24) (25) (26) . However, recent evidence shows structural heterogeneity in the NATI gene locus also, correlating with N-acetylation activity distinct from that typified by isoniazid and sulfamethazine (27, 28) . It has been suggested that NATI is primarily responsible for NAT activity in human uroepithelium (29) , and correlation between NATI polyadenylation signal polymorphism and risk of colorectal cancer has been reported (30) .
Given (35) . Interestingly, the presence of the GSTMI gene was recently correlated with induction of only low levels of CYPlAl mRNA (36) .
The protecting role of GSTMI gene in environmental exposures was supported by a study among Finnish asbestos workers, where the GSTMJ null genotype was associated with a 2-fold risk (OR 1.8, 95% CI 1.0-3.5) of asbestos-associated malignant mesothelioma (37 (30) .
Given the substrate specificities of the GSTs, individuals with null genotypes at both GSTMI and GSTTI may be at particular risk of environmentally induced cancers. To date, only a few studies have addressed this issue comprehensively. Warwick and co-workers (38) studied the role of combinations of CYP2D6, GSTMI, and GSTTI genotypes in susceptibility to cervical intraepithelial neoplasia and squamous cell carcinoma of the lung. In this study, no combined effect was detected for the two GST genes. However, the CYP2D6 extensive metabolizer (EM) genotype and the GSTTI null genotype were shown to be important risk factors for these pulmonary disorders, both individually and in combination. The GSTTI null and CYP2D6 PM genotypes were shown recently to also increase the risk for two common pituitary brain tumors, astrocytoma and meningioma, but no interactive effects between the genotypes were identified (15) . Moreover, in another study, no association between the CYP2D6 or GSTMJ genotypes and susceptibility to the pituitary tumors was detected (39) .
Since the recently observed association between the GSTTI null genotype and total ulcerative colitis was also shown to be uninfluenced by the GSTMI genotype (40) , the yet published data does not indicate concurrent deficiency of the GSTMI and GSTTI genes playing an important role in individual disease proneness. However, our preliminary findings that this genotype composition poses about a 2.5-fold risk of lung cancer compared to the presence of both of the GST genes (Saarikoski et al., unpublished data) warrant more thorough evaluation of this issue. Finally, the combined effect of CYP2EI and GSTMI genotypes was examined in a study suggesting a 2. (42) . No relation was found between these genes and the Band T-micronuclei formation in PAHexposed chimney sweeps (43, 44) ; the only statistically significant deviation was a 60% increase in aromatic DNA-adduct levels in GSTMI null chimney sweeps without any CYPIAI m2 alleles compared to controls with the same genotype composition (44) .
However, the GSTMI null genotype has been associated with significantly higher aromatic DNA adduct levels in bus maintenance workers with the NA T2 slow acetylator genotype compared to those with the GSTMI gene (45) . In a similar study, nonsmoking bus drivers with NA T2 slow acetylator genotype and GSTMI null genotype had the highest levels of both DNA adducts and cytogenetic damage (46) . Moreover, aminobiphenyl-hemoglobin adduct levels are most elevated in smokers possessing this combination of genotypes compared to smokers with other combinations (47) . Carcinogenic DNA adduct levels in the mucosa of the urinary bladder were highest in arylamine-exposed individuals who had inherited both the slow NA T2 acetylator genotype and the rapid NAT1 acetylationassociated allele NAT] *10 (48), further addressing the potential importance of individual acetylation capacity.
Conclusion
Knowledge of the genetic basis for variations in human metabolic capacity has opened new possibilities for studies focusing on the role of host factors in susceptibility to environmentally induced diseases. Rapid advances in methodology that determines potential metabolic at-risk genotypes, in combination with exposure markers such as DNA adduct levels in target (surrogate) tissues, may soon allow us to identify susceptible individuals and subgroups in environmentally exposed populations. However, the establishment of combined impact .of all relevant genes for a given exposure is anticipated to be a prerequisite for this.
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